Statins are indicated for the prevention of heart disease and stroke in specific populations

the verdict

SUPPORTED

the evidence backs this

Recorded sources

3 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Extensive clinical trial evidence and guidelines establish that statins are indicated for the prevention of heart disease and stroke in specific populations, particularly those at elevated cardiovascular risk.

The analysis

The claim states that statins are indicated for the prevention of heart disease and stroke in specific populations. Multiple retrieved papers, including large-scale meta-analyses and reviews, overwhelmingly support the efficacy of statins in preventing major adverse cardiovascular events, myocardial infarction, and stroke.

Evidence for · 3

Sources of Heterogeneity in the Efficacy of Statins for Primary Prevention of Cardiovascular Diseases: A Systematic Review with Meta-Regression and Meta-Analysis of Within-Study Subgroup Differences.

Recorded source metadata

Long Y, Liu J, Cai J, Zhuang Q, Cai T, Zhou J, Chai S, Lin T, Yang Z. Sources of Heterogeneity in the Efficacy of Statins for Primary Prevention of Cardiovascular Diseases: A Systematic Review with Meta-Regression and Meta-Analysis of Within-Study Subgroup Differences.. 2026. https://doi.org/10.1007/s10557-026-07883-6

This systematic review and meta-analysis of randomized controlled trials confirms that statin treatment significantly reduces major adverse cardiovascular events, myocardial infarction, and stroke in populations without prior cardiovascular disease.

Source citation format

See more details

More for · 2

Repurposed Drugs and Cardiovascular Morbidity: A Cost-Effectiveness Analysis.

Recorded source metadata

Leah OM, Leaşu FG, Badea M, Constantinescu M, Vârciu M, Rogozea LM. Repurposed Drugs and Cardiovascular Morbidity: A Cost-Effectiveness Analysis.. 2026. https://doi.org/10.1097/mjt.0000000000002156

This study identifies statins as foundational, low-cost generic agents that provide robust mortality benefits and form the basis of cardiovascular prevention protocols.

Source citation format

Novel Approaches to Lipid Management: Beyond Statins and PCSK9 Inhibitors.

Recorded source metadata

Patel J, Shah S, Reddy A, Prajapati D, Pandya A, Sawhney S. Novel Approaches to Lipid Management: Beyond Statins and PCSK9 Inhibitors.. 2026. https://doi.org/10.14740/jocmr6523

This review highlights that statins remain the foundation of lipid management because they lower LDL-C and prevent cardiovascular events in recommended populations.

Source citation format

The paper trail · every fact has a biography

first checked01 Aug 2026

judged → SUPPORTED · 7501 Aug 2026

More receipts

Is it true that Phonological evolution involves regular processes of phoneme elision, vowel nasalization, and tonogenesis?Is it true that Hemangiomas are treatable with medication?Is it true that Research identifies forms of intelligence that diverge from standard IQ measures?

Random receipt →The Trust Wiki →

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.

Check your own claim

Challenge the receipt

I have a source that contradicts this verdict I have a source that supports it No source: request a receipt review Requests are recorded for review. This does not start an automatic check or guarantee a response time.

trust me, bro: win the argument, pass the class, survive peer review.

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work · Dispute this receipt